Stifel Maintains Buy on DexCom, Raises Price Target to $90

Benzinga Newsdesk www.benzinga.com Positive 76.7%

Neg 0% Neu 0% Pos 76.7%

Stifel analyst Jonathan Block maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $85 to $90.

Comments

No comments yet. Be the first!